Klotho Neurosciences, Stock Net Income
| KLTO Stock | 0.36 0.01 2.70% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Klotho Neurosciences,'s long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Net Loss | -6.2 M | -5.8 M | |
| Net Loss | -6.2 M | -5.8 M | |
| Net Loss | (0.32) | (0.30) |
Klotho | Net Income | Build AI portfolio with Klotho Stock |
Klotho Neurosciences, Company Net Income Analysis
Klotho Neurosciences,'s Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Klotho Neurosciences, Net Income | (6.15 M) |
Most of Klotho Neurosciences,'s fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Klotho Neurosciences, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Klotho Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Klotho Neurosciences, is extremely important. It helps to project a fair market value of Klotho Stock properly, considering its historical fundamentals such as Net Income. Since Klotho Neurosciences,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Klotho Neurosciences,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Klotho Neurosciences,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Klotho Neurosciences, reported net income of (6.15 Million). This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is notably higher than that of the company.
Klotho Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Klotho Neurosciences,'s direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Klotho Neurosciences, could also be used in its relative valuation, which is a method of valuing Klotho Neurosciences, by comparing valuation metrics of similar companies.Klotho Neurosciences, is currently under evaluation in net income category among its peers.
Klotho Fundamentals
| Return On Equity | -1.98 | ||||
| Return On Asset | -0.72 | ||||
| Current Valuation | 27.65 M | ||||
| Shares Outstanding | 72.54 M | ||||
| Shares Owned By Insiders | 21.23 % | ||||
| Shares Owned By Institutions | 2.61 % | ||||
| Number Of Shares Shorted | 500.27 K | ||||
| Price To Book | 2.66 X | ||||
| EBITDA | (5.79 M) | ||||
| Net Income | (6.15 M) | ||||
| Total Debt | 271.75 K | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (2.95 M) | ||||
| Short Ratio | 0.68 X | ||||
| Earnings Per Share | (0.30) X | ||||
| Beta | 2.42 | ||||
| Market Capitalization | 26.45 M | ||||
| Total Asset | 2.46 M | ||||
| Retained Earnings | (10.56 M) | ||||
| Working Capital | (1.09 M) | ||||
| Net Asset | 2.46 M |
About Klotho Neurosciences, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Klotho Neurosciences,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Klotho Neurosciences, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Klotho Neurosciences, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Klotho Neurosciences,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Klotho Neurosciences, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klotho Neurosciences, will appreciate offsetting losses from the drop in the long position's value.Moving together with Klotho Stock
Moving against Klotho Stock
| 0.67 | DSGN | Design Therapeutics | PairCorr |
| 0.67 | 0P6S | Bayer AG NA | PairCorr |
| 0.65 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.6 | VERA | Vera Therapeutics | PairCorr |
| 0.58 | VCYT | Veracyte | PairCorr |
The ability to find closely correlated positions to Klotho Neurosciences, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Klotho Neurosciences, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Klotho Neurosciences, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Klotho Neurosciences, to buy it.
The correlation of Klotho Neurosciences, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Klotho Neurosciences, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Klotho Neurosciences, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Klotho Neurosciences, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Klotho Neurosciences, Piotroski F Score and Klotho Neurosciences, Altman Z Score analysis. To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences, guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Klotho Neurosciences,. If investors know Klotho will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Klotho Neurosciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Klotho Neurosciences, is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences,'s value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Klotho Neurosciences,'s market value can be influenced by many factors that don't directly affect Klotho Neurosciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Klotho Neurosciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Klotho Neurosciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Klotho Neurosciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.